Company intelligence / Profile preview

PRP Concepts

Ownership: Private
Development stage: Commercial

Overview

PRP Concepts has commercialized the CASCADE Autologous Platelet System for advanced wound care. The system creates an autologous platelet-rich fibrin membrane that sustains growth factor release for 7–10 days when applied to chronic wounds. This technology is designed to optimize healing in cases where standard treatments are insufficient. No clinical trial results are detailed on their website; the product is marketed based on its FDA clearance and regenerative mechanism.

Therapeutic areas: DermatologyEndocrinology
Modalities: DeviceAutologous platelet-rich fibrin membrane (biologic device)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

CASCADE Autologous Platelet System

Commercial

Indications: Diabetic foot ulcer, Chronic wounds, Orthopedic injuries, Sports injuries, Atopic dermatitis

Beyond the preview

Go deeper on PRP Concepts.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRP Concepts.

Explore the full profile